MedPath

MENSSANA RESEARCH INC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:3

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Breath Test to Predict Breast Cancer and Outcome of Mammography

Conditions
Breast Cancer
Abnormal Mammogram, Unspecified
First Posted Date
2021-02-16
Last Posted Date
2021-02-16
Lead Sponsor
Menssana Research, Inc.
Target Recruit Count
1000
Registration Number
NCT04755829
Locations
๐Ÿ‡ฉ๐Ÿ‡ช

University of Erlangen, Erlangen, Germany

๐Ÿ‡ณ๐Ÿ‡ฑ

Zuyderland Medical Center, Heerlen, Netherlands

๐Ÿ‡ฌ๐Ÿ‡ง

Frimley Health NHS Foundation Trust, Middlesex, United Kingdom

A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer

Completed
Conditions
Breast Cancer
First Posted Date
2016-09-05
Last Posted Date
2018-10-29
Lead Sponsor
Menssana Research, Inc.
Target Recruit Count
500
Registration Number
NCT02888366
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Southern California, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Hackensack Medical Center, Mountainside Hospital, Montclair, New Jersey, United States

๐Ÿ‡บ๐Ÿ‡ธ

St. Michael's Medical Center, Newark, New Jersey, United States

and more 1 locations

Breath Test for Biomarkers in Humans Receiving Total Body Irradiation

Conditions
Radiation Injury
First Posted Date
2014-06-02
Last Posted Date
2015-04-07
Lead Sponsor
Menssana Research, Inc.
Target Recruit Count
30
Registration Number
NCT02152722
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Emory University, Atlanta, Georgia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Hackensack University Medical Center, Hackensack, New Jersey, United States

๐Ÿ‡บ๐Ÿ‡ธ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Heartsbreath Test for Heart Transplant Rejection

Conditions
Heart Transplant Rejection
First Posted Date
2011-07-20
Last Posted Date
2015-04-07
Lead Sponsor
Menssana Research, Inc.
Target Recruit Count
1200
Registration Number
NCT01397812
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cedars-Sinai Medical Center, Beverly Hills, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Stanford University School of Medicine, Stanford, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Newark Beth Israel Medical Center, Newark, New Jersey, United States

and more 2 locations

Breath Test for Early Detection of Lung Cancer

Completed
Conditions
Lung Neoplasms
First Posted Date
2008-03-19
Last Posted Date
2014-05-16
Lead Sponsor
Menssana Research, Inc.
Target Recruit Count
215
Registration Number
NCT00639067
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Christiana Hospital, Newark, Delaware, United States

๐Ÿ‡บ๐Ÿ‡ธ

MD Anderson Cancer Center, Orlando, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

New York University Medical Center, New York, New York, United States

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.